Strong market access but suffers from poor leadership - Recensione dipendente - Dipendente anonimo presso BridgeBio

2,0
6 lug 2026
Dipendente anonimo
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Excellent Medication, Strong Investment in Market Access, amazing launch

Svantaggi

Poor leadership, increasing negative culture, reactive leaders, withholding of important information, inexperienced leaders, blame culture

Esplora altre recensioni su BridgeBio

5,0
5 mag 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

great mission, people, and culture

Svantaggi

in office days are mandated

1,0
30 giu 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Compensation, some colleagues, nice office.

Svantaggi

In my experience, the company's culture changed significantly after it became successful. i observed a management style that I felt relied heavily on unjustified criticism and assigning blame rather than constructive feedback. Several employees, including high-performing contributors, appeared to leave after conflicts with senior leadership including the CMO. I felt concerns raised through HR were not addressed in a meaningful way and that employee perspectives were not given fair consideration during workplace disputes. Advancement and performance evaluations often seemed influenced by interpersonal relationships and alignment with management styles rather than merit alone. While the company states that it cares deeply about patients, I felt employee well-being received far less attention. The environment created significant streks and negatively affected morale. I would not recommend the company to individuals seeking a supportive workplace culture.

1
Vedi recensioni per: Utile|Valutazione|Data|Tutto